SK pharmteco Boosts Domestic Peptide Scale-Up with Investment in California Facility
Expansion leverages proprietary chromatography expertise to overcome purification bottlenecks and secure domestic API manufacturing
Expansion leverages proprietary chromatography expertise to overcome purification bottlenecks and secure domestic API manufacturing
SK pharmteco, a global contract development and manufacturing organization serving the pharmaceutical industry, today announced that David Lowndes will be appointed as Chief Operating Officer.
SK pharmteco, a global contract development and manufacturing organization (CDMO) serving the pharmaceutical industry, today announced that Joerg Ahlgrimm will be appointed as the Chief Executive Officer.
SK pharmteco, world-leaders in Continuous Flow Processing are hosting a free 1-Day Symposium for customers and key contacts on Thursday, October 13th at the Le Meridien Hotel, Cambridge, Boston, MA.
SK pharmteco (SKPT) a global CDMO, part of SK Inc., is pleased to announce Dollar 35m investment for the initial phase of an expansion plan for SK biotek Ireland’s Dublin-based pharmaceutical manufacturing plant.
Highlights from our discussion with Dr Bill DuBay, Vice President of Global Research and Development at SK pharmteco.